MedTrace Logo

European Registry of Next Generation Imaging in Advanced Prostate Cancer

NCT06866782 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-03-11

No results posted yet for this study

Summary

The RING study is a European registry collecting real-world data on advanced prostate cancer (APC) imaging. It aims to evaluate the role of next-generation imaging (NGI), such as PET/CT and whole-body MRI, in detecting and monitoring the disease compared to conventional imaging.

Men aged 18 or older with histologically confirmed prostate cancer are eligible to participate in the study if they require imaging to assess potential metastases, either at diagnosis or after relapse and sign a consent form.

Patients will receive standard care with no experimental treatments. Imaging and treatment decisions will follow routine clinical practice. Data will be collected from medical records and analysed for research. This study will help doctors understand when NGI should be used, how it affects treatment decisions, and its impact on patient outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Imaging

Imaging will be done according to local protocols and/or guidelines of EAU

Sponsors & Collaborators

  • European Association of Urology Research Foundation

    collaborator OTHER

  • GUARD Consortium (Genitourinary Alliance for Research and Development)

    collaborator UNKNOWN

  • European Association of Urology - Section of Urological Imaging

    collaborator UNKNOWN

  • Johnson & Johnson

    collaborator INDUSTRY

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    collaborator OTHER

  • Fundacio Puigvert

    lead OTHER

Principal Investigators

  • Francesco Sanguedolce, MD, PhD · Fundació Puigvert

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2025-12-23
Completion
2026-12-23

Countries

  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06866782 on ClinicalTrials.gov